Shuttle Pharmaceuticals Holdings (SHPH) Net Cash Flow (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Net Cash Flow history runs 6 years deep, the most recent figure standing at $755941.0 for Q1 2026.

• In Q1 2026, Net Cash Flow fell 70.84% year-over-year to $755941.0; the TTM figure through Mar 2026 stood at -$365939.0 (down 111.75% YoY), while the FY2025 annual figure was -$1.6 million, down 141.69% from the prior year.
• Net Cash Flow was $755941.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $1.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $9.1 million in Q3 2022 to a low of -$2.7 million in Q3 2025.
• Historically, Net Cash Flow has averaged $214230.5 across 5 years, with a median of -$538938.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow tumbled 1161.92% in 2023, then jumped 320.11% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$703187.0 in 2022, then sank by 86.24% to -$1.3 million in 2023, then surged by 234.66% to $1.8 million in 2024, then decreased by 26.5% to $1.3 million in 2025, then slumped by 41.67% to $755941.0 in 2026.
• The last three Net Cash Flow figures came in at $755941.0 (Q1 2026), $1.3 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.